Newly-minted Signant Health named a new CTO, Parexel bolstered its Japan presence, and BioAgilytix’s CEO was appointed to the board of FSD Pharma – a company developing products based on cannabinoids – among other people on the move in June.
Lonza Small Molecules | 28-Mar-2023
| Technical / White Paper
A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...
Elligo Health Research® | 23-Mar-2023
| Insight Guide
On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...
Elligo Health Research® | 10-Mar-2023
| Insight Guide
You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...
